More than 7-year survival of a patient following repeat hepatectomy for total 20 colon cancer liver metastases by Yang, Kwang Ho et al.
Copyright © 2012, the Korean Surgical Society




Journal of the Korean Surgical Society
 pISSN 2233-7903ㆍeISSN 2093-0488
Received June 7, 2011, Revised July 18, 2011, Accepted August 16, 2011
Correspondence to: Chong Woo Chu 
Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Pusan National University Yangsan Hospital, 
Pusan National University School of Medicine, Beomeo-ri, Mulgeum-eup, Yangsan 626-770, Korea
Tel: ＋82-55-360-2476, Fax: ＋82-55-360-2154, E-mail: liversurgeon@hanmail.net
cc  Journal of the Korean Surgical Society is an Open Access Journal. All articles are distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
More than 7-year survival of a patient following repeat 
hepatectomy for total 20 colon cancer liver metastases
Kwang Ho Yang
1,2, Je Ho Ryu
1, Ki Myung Moon
1, Chong Woo Chu
1,2
1Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Pusan National University Yangsan 
Hospital, Pusan National University School of Medicine, 
2Research Institute for Convergence of Biomedical Science and Technology, 
Pusan National University Yangsan Hospital, Yangsan, Korea
A 54-year-old man was transferred with sigmoid colon cancer combined with multiple bilobar liver metastases. Nine meta-
stases were in the left lobe and 5 metastases were in the right lobe. After low anterior resection, all 9 lesions in the left lobe 
were completely removed by wedge resections. Because the remnant liver volume after multiple wedge resection of the left 
lobe was not sufficient to perform a right hepatectomy simultaneously, we planned a two-stage hepatectomy. Right portal 
vein embolization was performed one week after the first liver operation. A right hepatectomy was safely performed 22 days 
after the first hepatectomy. A recurrent mass developed in the segment III 18 months after the right hepatectomy. 
Radiofrequency ablation (RFA) was performed to remove that lesion. Five other metastases developed 18 months after RFA 
whereby multiple wedge resections were performed. The patient has survived for more than 7 years after the first liver 
operation. 
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INTRODUCTION
Curative hepatic resection is currently accepted as the 
most effective treatment for patients with colorectal can-
cer liver metastases (CRLM). Recent reports showed that 
the mortality rate has decreased to less than 1%, and 5-year 
survival rates have increased after hepatectomy in these 
patients [1]. However, only 10 to 20% of the patients with 
CRLM are eligible for curative surgical procedures at the 
time of presentation [2]. The main cause of this low resect-
ability is multiple bilobar liver metastases (MBLM). To 
overcome this problem, multidisciplinary approaches 
were produced such as neoadjuvant chemotherapy, radio-
frequency ablation (RFA), portal vein embolization (PVE), 
and two-stage hepatectomy [3]. Another problem is that 
the recurrent metastatic disease develops in most patients 
after liver resection, which mainly occurs in the liver. In 
this situation, repeat hepatectomy for recurrent liver 
metastasis can be performed safely and provide survival 
benefits [4]. 
In the case presented here, a patient initially had MBLM 
and recurrent lesions develop twice, yet, he was success-7-year survival after resection of multiple CRLM
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Fig. 1. Initial abdominal ultrasonography and computed tomography. Four lesions in left lobe and 5 lesions in right lobe were found (white 
arrow, metastases in left lobe; black arrow, metastases in right lobe).
fully managed with multidisciplinary approaches. The 
patient is now alive without disease, for more than 7 years 
after initial operation.
CASE REPORT
A 54-year-old man was referred to our department with 
sigmoid colon cancer combined with MBLM in November 
2003. The sigmoid colon cancer infiltrated the pericolic fat 
tissue without lymph node invasion in the preoperative 
colon study. Nine metastatic lesions were preoperatively 
detected in the liver (5 lesions in the right lobe and 4 le-
sions in the left lobe) (Fig. 1). Mean size of right side lesions 
was 4.3 ± 1.2 cm and mean size of left side lesions was 1.5 
± 0.6 cm. We planned to resect the sigmoid colon cancer 
and perform staged hepatectomy; a simultaneous right 
hepatectomy with wedge resection of the left side meta-
stases. The preoperative carcinoembryonic antigen (CEA) 
level was 75.9 ng/mL.
The sigmoid colon cancer was completely removed by 
low anterior resection. The pathologic findings of the sig-
moid colon cancer specimen were moderately differen-
tiated adenocarcinoma, pericolic fat tissue infiltration, 
and no invasion of lymph nodes. 
The staged hepatectomy was carried out 10 days after 
low anterior resection. Intraoperative ultrasonography 
(IOUS) was performed to detect the hepatic metastatic 
lesions. In contrast to the preoperative findings, a total of 
9 lesions were detected in the left lobe. Therefore, we de-
vised a new plan to perform non-anatomical resection of 
left side metastases followed by right hepatectomy after 
increasing the expected remnant liver volume. Mean size 
of left lobe lesions was 10 ± 2 mm. All lesions of the left lobe 
were completely removed with the cavitron ultrasonic 
surgical aspirator (CUSA; Integra LifeSciences Co., Plains-
boro, NJ, USA). Abdominal computed tomography (CT) 
was checked the day after the first operation and the ex-Kwang Ho Yang, et al.
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Fig. 2. (A) Abdominal computed tomography (CT) that was checked the day after first hepatectomy. Expected remnant liver volume was 
measured to be 29.5%. (B) Abdominal CT that was performed three weeks after first hepatectomy. Expected remnant liver volume increased 
to 35.8%. (C) Hypertrophied left lobe found in second hepatectomy. (D) Right hepatectomy was performed according to anatomical 
demarcation line.
pected remnant liver volume was measured at 29.5% (Fig. 
2A). Embolization of the right portal vein was performed 
one week after the first hepatectomy. The patient recov-
ered uneventfully. Abdominal CT was performed three 
weeks after the first operation and the expected remnant 
liver volume had increased to 35.8% (Fig. 2B). No meta-
static lesions of the non-anatomically resected left lobe 
were found in the CT.
The second-stage operation was consequently per-
formed 22 days after the first liver operation. Hypertro-
phied left lobe was found (Fig. 2C). IOUS was rechecked to 
determine any metastatic lesions in the future remnant liv-
er and there were no lesions. Therefore, the right hep-
atectomy was safely performed (Fig. 2D). The CEA level 
was 2.67 ng/mL 10 days after the second liver operation. 
The patient received 9 cycles of infusional 5-fluorouracil, 
leucovorin, and oxaliplatin (FOLFOX-4) chemotherapy af-
ter two-stage hepatectomy.
A recurred mass developed in segment III 18 months af-
ter the second liver operation (Fig. 3B). Extracorporeal 
RFA was performed to remove a recurrent lesion. After 
RFA, the patient received 12 cycles of oral capecitabine. 
Unfortunately, 5 other metastases developed 18 months 
after RFA (Fig. 4). The third liver operation was performed 
and all metastatic lesions were completely removed by 
multiple wedge resections. The patient recovered un-
eventfully and received 6 cycles of infusional 5-fluorour-
acil, leucovorin, and irinotecan (FOLFIRI) chemotherapy 
after the third operation. He has survived for more than 7 
years after the first operation (Fig. 5). The last CEA level 
was 3.35 ng/mL.
DISCUSSION
Over the last decade, the concept of treatment for CRLM 7-year survival after resection of multiple CRLM
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Fig. 3. (A) Abdominal computed tomography (CT) taken at 15 months after second-stage hepatectomy showed no recurrent lesion. (B) 
Magnetic resonance image taken at 18 months after second-stage hepatectomy. Single recurrent mass (arrow) developed in remaining liver. 
(C) Abdominal CT checked after radiofrequency ablation (arrow, post-radiofrequency ablation lesion). (D) Abdominal CT taken at 14 months
after radiofrequency ablation showed no other recurrent lesion (arrow, post-radiofrequency ablation lesion).
has significantly changed. Many therapeutic options were 
introduced for curative hepatic resection, such as a novel 
regimen of chemotherapy, PVE, staged hepatic resection 
and RFA. As a result, more patients with CRLM could be-
come candidates for curative surgical resections.
Traditionally, hepatectomy has been considered a con-
troversial treatment strategy in cases with the presence of 
4 or more colorectal metastatic lesions. However, recent 
studies have shown good results after hepatic resection in 
such cases [5]. Of particular interest, Imamura et al. [6] re-
ported a case in which a patient had 22 metastatic nodules 
and underwent PVE and repeated hepatic resections. The 
author reported that disease-free survival time was 5 years 
4 months after the repeat hepatic resection. Minagawa et 
al. [5] reported that 10-year survival rate of patients with 4 
or more metastases after hepatic resection was 29%, which 
was almost equal to the long-term survival of patients 
with one solitary lesion. At present, it has been generally 
accepted that the number of metastases does not sig-
nificantly influence prognosis, if satisfactory resection 
could be achieved [5].
As one such innovative modality, two-stage hepatec-
tomy with PVE was produced to increase curability in pa-
tients with MBLM. PVE can be used to induce compensa-
tory hypertrophy of the future remnant liver in patients 
who have inadequate liver volume. However, it also car-
ries potential negative side effects. PVE can be associated 
with promotion of tumor growth in the future remnant 
liver [7], and enhancement of the disease recurrence [8]. 
Therefore, two-stage hepatectomy was developed. Meta-
stases in the future remnant liver should ideally be re-
sected before PVE. Then, major hepatic resection can be 
performed after PVE in patients with initially unresectable 
MBLM. Adam et al. [9] were the first to report a case un-
dergoing this two-stage hepatectomy procedure com-
bined with PVE. Unfortunately, the patient died of post-Kwang Ho Yang, et al.
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Fig. 4. Abdominal computed tomography and magnetic resonance image taken at 36 months after second-stage hepatectomy (arrows, 
multiple recurrent lesions).
Fig. 5. Abdominal computed tomography taken at 7 years after initial hepatectomy. No recurrent lesion was found. 
operative complications. Jaeck et al. [7] then reported that 
this strategy was successfully applied to patients with ini-
tially unresectable MBLM. In our case, two-stage hep-
atectomy with PVE was applied and the initial 14 lesions 
were completely resected. IOUS by a specialist also greatly 
contributed to removing all lesions. 
Unfortunately, 60 to 70% of patients undergoing liver 
resection for colorectal metastases develop disease recur-
rence. Several articles have reported that one-third of pa-
tients with recurrent liver metastases are suitable for re-
peat liver resection [10]. And repeat hepatectomy for pati-
ents with CRLM is a safe procedure that can provide long- 
term survival equal to that of a previous hepatectomy [4]. 
RFA may be an alternative therapeutic option for recur-
rent lesions, but to date, no randomized, controlled trials 
of outcome of RFA for recurrence of CRLM compared with 7-year survival after resection of multiple CRLM
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surgical resection exist; and the role of RFA is not yet well 
defined. In our case, the patient was successfully treated 
with RFA for one lesion and repeat wedge resections for 
five lesions in second recurrence.
In conclusion, we have reported that 20 accumulated 
metastatic lesions were successfully managed with multi-
disciplinary and aggressive approaches in a patient with 
MBLM from colorectal origin. The patient is now alive 
without recurrence, more than 7 years after initial opera-
tion.
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